SODIUM 4-((4-CHLORO-6-ISOPROPOXY-1,3,5-TRIAZIN-2-YL)AMINO)-2-(2-(1-(2-CHLORO-6-METHYLPHENYL)-3-METHYL-5-OXO-4H-PYRAZOL-4-YL)DIAZEN-1-YL)BENZENESULFONATE
UNII 158LQ9WJ3G
Substance Identification & Data
This profile provides standardized clinical and technical data for Sodium 4-((4-chloro-6-isopropoxy-1,3,5-triazin-2-yl)amino)-2-(2-(1-(2-chloro-6-methylphenyl)-3-methyl-5-oxo-4h-pyrazol-4-yl)diazen-1-yl)benzenesulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 158LQ9WJ3G.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 89923-50-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H21Cl2N8O5S.Na JCLZURRMXYPTOR-FJISBNMDSA-M Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Sodium 4-((4-chloro-6-isopropoxy-1,3,5-triazin-2-yl)amino)-2-(2-(1-(2-chloro-6-methylphenyl)-3-methyl-5-oxo-4h-pyrazol-4-yl)diazen-1-yl)benzenesulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.